Cytek Biosciences, Inc. CTKB Deferred income
Deferred income at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredRevenueNoncurrent.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s deferred income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s deferred income?
- Cytek Biosciences, Inc. (CTKB) reported deferred income of $17.67M in Q1 2026.
- How has Cytek Biosciences, Inc.'s deferred income changed year-over-year?
- Cytek Biosciences, Inc.'s deferred income increased by 12.4% year-over-year, from $15.72M to $17.67M.
- What is the long-term trend for Cytek Biosciences, Inc.'s deferred income?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s deferred income has grown at a 39.6% compound annual growth rate (CAGR), from $3.46M to $18.34M.